FR2722207B1 - Methode pour generer une population de cellules presentant a leur surface une forte densite d'un pepride exogene specifique associe azx molecules du cmh; population de cellules - Google Patents

Methode pour generer une population de cellules presentant a leur surface une forte densite d'un pepride exogene specifique associe azx molecules du cmh; population de cellules

Info

Publication number
FR2722207B1
FR2722207B1 FR9408427A FR9408427A FR2722207B1 FR 2722207 B1 FR2722207 B1 FR 2722207B1 FR 9408427 A FR9408427 A FR 9408427A FR 9408427 A FR9408427 A FR 9408427A FR 2722207 B1 FR2722207 B1 FR 2722207B1
Authority
FR
France
Prior art keywords
population
pepride
azx
cells
generating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9408427A
Other languages
English (en)
Other versions
FR2722207A1 (fr
Inventor
Demoyen Pierre Langlade
Philippe Kourilsky
Jean Pierre Abastado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR9408427A priority Critical patent/FR2722207B1/fr
Priority to AU29303/95A priority patent/AU2930395A/en
Priority to PCT/FR1995/000907 priority patent/WO1996001891A1/fr
Publication of FR2722207A1 publication Critical patent/FR2722207A1/fr
Application granted granted Critical
Publication of FR2722207B1 publication Critical patent/FR2722207B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464402—Receptors, cell surface antigens or cell surface determinants
    • A61K39/464403—Receptors for growth factors
    • A61K39/464406—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ ErbB4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464448—Regulators of development
    • A61K39/46445—Apoptosis related proteins, e.g. survivin or livin
    • A61K39/464451—Apoptosis related proteins, e.g. survivin or livin p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464484—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/464486—MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR9408427A 1994-07-07 1994-07-07 Methode pour generer une population de cellules presentant a leur surface une forte densite d'un pepride exogene specifique associe azx molecules du cmh; population de cellules Expired - Fee Related FR2722207B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9408427A FR2722207B1 (fr) 1994-07-07 1994-07-07 Methode pour generer une population de cellules presentant a leur surface une forte densite d'un pepride exogene specifique associe azx molecules du cmh; population de cellules
AU29303/95A AU2930395A (en) 1994-07-07 1995-07-06 Method for generating a population of cells having a high surface density of a mhc molecule-associated specific exogenous peptide, and cell population
PCT/FR1995/000907 WO1996001891A1 (fr) 1994-07-07 1995-07-06 Methode pour generer une population de cellules presentant a leur surface une forte densite d'un peptide exogene specifique associe aux molecules du cmh; population de cellules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408427A FR2722207B1 (fr) 1994-07-07 1994-07-07 Methode pour generer une population de cellules presentant a leur surface une forte densite d'un pepride exogene specifique associe azx molecules du cmh; population de cellules

Publications (2)

Publication Number Publication Date
FR2722207A1 FR2722207A1 (fr) 1996-01-12
FR2722207B1 true FR2722207B1 (fr) 1996-09-27

Family

ID=9465136

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9408427A Expired - Fee Related FR2722207B1 (fr) 1994-07-07 1994-07-07 Methode pour generer une population de cellules presentant a leur surface une forte densite d'un pepride exogene specifique associe azx molecules du cmh; population de cellules

Country Status (3)

Country Link
AU (1) AU2930395A (fr)
FR (1) FR2722207B1 (fr)
WO (1) WO1996001891A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1000628A1 (fr) * 1998-09-28 2000-05-17 Fondation Mondiale Recherche et Prevention SIDA Utilisation de complexes antigènes de l'enveloppe de VIH et des antigènes HLA classe I comme vaccin contre le VIH
US7029339B2 (en) 2001-08-30 2006-04-18 Siemens Aktiengesellschaft Shock-proof electric marine engine, e.g. engine or generator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4948890A (en) * 1989-01-12 1990-08-13 Blood Center Of Southeastern Wisconsin, The Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses
US5364762A (en) * 1990-03-21 1994-11-15 Board Of Trustees Of The Leland Stanford Junior University Major histocompatibility complex (MHC) molecules
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
EP0643726B1 (fr) * 1992-05-26 1999-08-18 Rijksuniversiteit te Leiden Peptides de la proteine p53 humaine destines a etre utilises dans des compositions induisant une reaction chez les lymphocytes t humains, et lymphocytes t cytotoxiques specifiques de la proteine p53 humaine

Also Published As

Publication number Publication date
WO1996001891A1 (fr) 1996-01-25
AU2930395A (en) 1996-02-09
FR2722207A1 (fr) 1996-01-12

Similar Documents

Publication Publication Date Title
FR2623271B1 (fr) Procede de stockage d'hydrogene et materiaux pour electrodes d'hydrure
ID17599A (id) Proses memproduksi asam tereftalat berkemurnian tinggi dengan menggunakan peralatan pengganti media dispersi
DK325189D0 (da) Fremgangsmaade til indfoering af molekyler, isaer genetisk materiale, i cellemateriale samt apparat til anvendelse ved udoevelse af fremgangsmaaden
DE69429531T2 (de) Elektrolytische zelle zur herstellung eines oxidierenden gasgemisches
ES2072606T3 (es) Laminas de espuma de polipropileno.
DK1018123T3 (da) Beholder med magnetisk afskærmning
MY101015A (en) Splice case for optical fibre cable.
AU5493201A (en) Method for introduction of molecules into cells
ATE213271T1 (de) Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte- fermentation
DK306890D0 (da) Udtrykkelse af celleproliferation med decorin
AU2387795A (en) Culture medium for maintaining viability of mammalian cells
IL99547A0 (en) Method of introducing foreign dna into cells
FR2714212B1 (fr) Plaque d'électrode à support de type mousse métallique pour générateur électrochimique et procédé pour fabriquer une telle plaque d'électrode.
JPH0513463B2 (fr)
IT1229874B (it) Procedimento per migliorare il trasporto di materia ad un elettrodo in una cella a diaframma e mezzi idrodinamici relativi.
FR2714213B1 (fr) Plaque d'électrode à support de type mousse métallique pour générateur électrochimique, et procédé d'obtention d'une telle électrode.
DE69832244D1 (de) Vorrichtung zur Wiedergabe und Aufzeichnung eines optischen Speichermedium
FR2722207B1 (fr) Methode pour generer une population de cellules presentant a leur surface une forte densite d'un pepride exogene specifique associe azx molecules du cmh; population de cellules
ZA917561B (en) Media for culture of mammalian cells
IT8320747A0 (it) Metodo per produrre carbonio ad alta densita'.
DE59205882D1 (de) Brennstoffzelle und verfahren zur befeuchtung des elektrolyten
DE69527514T2 (de) Gen eines zelloberflächenpolypeptids
NO961749L (no) Forbedret celledyrkningsfremgangsmåte og -medium
NO974367D0 (no) Vektorer samt fremgangsmåter for gen-ekspresjon i pattedyrceller
ITMI912981A1 (it) Procedimento ed apparecchiatura per fabbricare un supporto di elettrolita solido di cella elettrochimica

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse